WA-KYMETA
2.12.2020 10:36:09 CET | Business Wire | Press release
Kymeta (www.kymetacorp.com )—the communications company making mobile global—announced that the Kymeta™ u8 and Kymeta Connect™ are available for government and commercial purchase after November 30, 2020, unlocking the potential of broadband satellite connectivity and cellular networks to satisfy the overwhelming demand for communications on the move.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005022/en/
Kymeta’s next-generation solutions are built for mobility and designed to meet the needs of global defense agencies, government, first responders, and commercial customers. Kymeta’s products and services have been field deployed for three years and the demand for the Kymeta u8 presales has already exceeded expectations. With the introduction of the Kymeta u8, the company has meaningfully increased antenna throughput and significantly reduced the total cost of ownership. Kymeta’s new products and services offer a breakthrough in performance, ease of use, and affordability, and it anticipates that these solutions will further enhance its position in both commercial and government markets, further increasing its lead over competitive offerings.
“Government and military need the most reliable and seamless connectivity to safely fulfill their missions,” said Walter Berger, Kymeta President, and COO. “These men and women often go to the most remote or disaster-stricken areas of the world, and they need reliable communications to rescue lives, keep property safe, and complete missions. Our government, military, and commercial customers trust Kymeta solutions. The enhanced performance of the u8 is helping our customers make fast, easy, and reliable mission-critical communications on the move a reality.”
The launch of Kymeta’s next-generation solutions builds on the successful deployment of our beta program earlier this year to facilitate real-world testing. The testing demonstrated throughputs of over 45Mbps in land mobile environment with large scan-off angles of over 50 degrees, which is a remarkable achievement for such a low power (<150W) electronically steered antenna platform. The u8 was tested in regions around the world including North America, APAC, and Europe, in a variety of conditions confirming that the product can be operated with confidence even under the most trying scenarios.
“My team works in some of the most densely populated, rugged, and steep forest terrain in the U.S.,” said Tim Dunfee, Deputy Forest Fire Chief, U.S. Forest Service. “There are places across our varied terrain that have been engulfed by fires and communications cell towers that have been destroyed, causing loss of all communications. When we tested Kymeta’s solutions, we could use FaceTime and make voice calls for the first time. We now have a Kymeta antenna installed on one of our vehicles and deploy it to every forest fire because we know it has reliable communications wherever it goes.”
The Kymeta u8 covers the full Ku-band and is designed to be LEO upgradeable. The u8 is available as an antenna, an ODU (with no modem), and a turnkey terminal with embedded satellite modem, cellular modem, and SD-WAN capabilities. The Kymeta terminals are easy to set up and they acquire service within minutes of being powered. Also coming soon is a transportable configuration called the u8 GO, which is ideal for rapid deployments. The u8 GO will enable safe transport with a hardened case for protection and provides a built-in car mount to support easy operations on the pause and on the move.
Combining the u8 with Kymeta’s hybrid satellite-cellular connectivity services, Kymeta Connect transforms the purchase and consumption of mobile data delivering a complete end-to-end solution with a best-in-industry customer experience. The all-inclusive hybrid satellite-cellular connectivity, global support, and network services package start at $999 per month.
Kymeta Connect is powered by a virtual architecture consisting of an operational stack that connects remote terminals to managed satellite and cellular services, integrates a state-of-the-art digital back office for service and subscription management, and includes an operations and care element to deliver an excellent customer experience. These services are augmented with a unique application called Access which simplifies the control, management, and monitoring of all hardware and connectivity solutions. The newly announced app is available for download through the Apple and Google Play stores. Today, Kymeta Access can be used on a tablet or through a web-based portal to interact with hardware, data, customer care, and subscription services.
Kymeta expects to further accelerate its new product development and commercialization of its next-generation solutions and looks forward to sharing more in 2021.
About Kymeta
Kymeta is unlocking the potential of broadband satellite connectivity, combined with cellular networks, to satisfy the overwhelming demand for comms on the move and making mobile global. Lepton Global Solutions, a Kymeta company, hosts the company’s satellite connectivity solutions and offers unique, complete, and turnkey bundled solutions to the market based on best in class technologies and tailored customer-centric services that meet and exceed customer mission requirements. These solutions in tandem with the company’s flat-panel satellite antenna, the first of its kind, and Kymeta Connect™ services provide revolutionary mobile connectivity on satellite and hybrid satellite-cellular networks to customers around the world. Backed by U.S. and international patents and licenses, the Kymeta terminal addresses the need for lightweight, slim, and high-throughput communication systems that do not require mechanical components to steer toward a satellite. Kymeta makes connecting easy – for any vehicle, vessel, or fixed platform.
Kymeta is a privately held company based in Redmond, Washington.
For more information, visit kymetacorp.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201130005022/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release
Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 03:00:00 CEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 00:00:00 CEST | Press release
On average, about 75% of patients with scalp psoriasis treated with zasocitinib achieved clear or almost clear skin at week 16 Approximately 70% of patients with palmoplantar disease treated with zasocitinib achieved clear or almost clear skin at week 16 Zasocitinib demonstrated statistically significant improvements in Nail Psoriasis Severity Index (NAPSI) versus placebo Results reinforce the potential of zasocitinib to deliver rapid and durable skin clearance, including in the hardest-to-treat areas, in a convenient once-daily pill Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance16.7.2026 23:36:00 CEST | Press release
Debut transaction more than three times oversubscribed The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful plac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom